SG55145A1 - Hematopoietic facilitatory cells and their uses - Google Patents

Hematopoietic facilitatory cells and their uses

Info

Publication number
SG55145A1
SG55145A1 SG1996007923A SG1996007923A SG55145A1 SG 55145 A1 SG55145 A1 SG 55145A1 SG 1996007923 A SG1996007923 A SG 1996007923A SG 1996007923 A SG1996007923 A SG 1996007923A SG 55145 A1 SG55145 A1 SG 55145A1
Authority
SG
Singapore
Prior art keywords
bone marrow
cells
marrow cells
hematopoietic
engraftment
Prior art date
Application number
SG1996007923A
Other languages
English (en)
Inventor
Suzanne T Ildstad
Richard L Simmons
Camillo Ricordi
Sherry M Wren
Christina Kaufmann
Original Assignee
Univ Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pittsburgh filed Critical Univ Pittsburgh
Publication of SG55145A1 publication Critical patent/SG55145A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/22—Immunosuppressive or immunotolerising
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/416—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/418—Antigens related to induction of tolerance to non-self
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/50—Cellular immunotherapy characterised by the use of allogeneic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG1996007923A 1992-07-10 1993-07-09 Hematopoietic facilitatory cells and their uses SG55145A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91198992A 1992-07-10 1992-07-10
US99654492A 1992-12-24 1992-12-24
US6931593A 1993-05-28 1993-05-28

Publications (1)

Publication Number Publication Date
SG55145A1 true SG55145A1 (en) 1998-12-21

Family

ID=27371514

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996007923A SG55145A1 (en) 1992-07-10 1993-07-09 Hematopoietic facilitatory cells and their uses

Country Status (12)

Country Link
EP (1) EP0652943B1 (de)
JP (1) JP3917652B2 (de)
AT (1) ATE399854T1 (de)
AU (1) AU688734B2 (de)
CA (1) CA2139877C (de)
DE (1) DE69334227D1 (de)
DK (1) DK0652943T3 (de)
ES (1) ES2309985T3 (de)
NZ (2) NZ255039A (de)
PT (1) PT652943E (de)
SG (1) SG55145A1 (de)
WO (1) WO1994001534A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG54291A1 (en) * 1994-01-05 1998-11-16 Univ Pittsburgh Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells
WO1996015227A1 (en) * 1994-11-14 1996-05-23 Novartis Ag Methods of inducing cell death of primitive hematopoietic cells and compositions for induction thereof
AU739277B2 (en) * 1997-09-10 2001-10-11 Emory University Methods for inhibiting rejection of transplanted tissues by bone grafting
ZA200704252B (en) 2004-10-25 2009-09-30 Cellerant Therapeutics Inc Methods of expanding myeloid cell populations and uses thereof
CN101421393B (zh) 2006-02-14 2013-08-14 塞勒兰特治疗公司 提高造血干细胞植入的方法和组合物
US8632768B2 (en) * 2008-05-30 2014-01-21 University Of Louisville Research Foundation, Inc. Human facilitating cells
JP6401445B2 (ja) * 2013-10-10 2018-10-10 国立大学法人 東京大学 造血幹細胞移植用の組合せ細胞製剤および生着促進剤並びにこれらの製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061620A (en) * 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
EP0667904B1 (de) * 1991-11-05 2002-02-20 The Board Of Trustees Of The Leland Stanford Junior University Suppressorzellen

Also Published As

Publication number Publication date
EP0652943B1 (de) 2008-07-02
NZ299935A (en) 2000-07-28
CA2139877A1 (en) 1994-01-20
WO1994001534A1 (en) 1994-01-20
PT652943E (pt) 2008-10-09
ES2309985T3 (es) 2008-12-16
HK1010739A1 (en) 1999-06-25
DE69334227D1 (de) 2008-08-14
JPH08500009A (ja) 1996-01-09
NZ255039A (en) 1997-03-24
EP0652943A1 (de) 1995-05-17
CA2139877C (en) 2006-09-19
EP0652943A4 (de) 1996-02-07
AU4771793A (en) 1994-01-31
JP3917652B2 (ja) 2007-05-23
ATE399854T1 (de) 2008-07-15
AU688734B2 (en) 1998-03-19
DK0652943T3 (da) 2008-11-03

Similar Documents

Publication Publication Date Title
Luria et al. Bone formation in organ cultures of bone marrow
Lawler et al. Cytogenetic studies on recipients of allogeneic bone marrow using the sex chromosomes as markers of cellular origin
CA2121370A1 (en) Specific tolerance in transplantation
HUS1400034I1 (hu) Dialkil-fumarátok alkalmazása autoimmun betegségek kezelésére szolgáló gyógyászati készítmények elõállítására
PL367544A1 (en) Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis
WO2003012060A3 (en) Cellular compositions which facilitate engraftment of hematopoietic stem cells while minimizing the risk of gvhd
IL141877A0 (en) Pharmaceutical compositions containing alpha4 integrin antagonists
WO2001094541A3 (en) Human mesenchymal progenitor cell
WO2002040049A3 (en) Blockade of t cell migration into epithelial gvhd target tissues
IL141813A (en) Mixture comprising bone marrow cells together with demineralized and/or mineralized bone matrix and uses thereof in the preparation of compositions for the treatment of hematopoietic dusirders
IL153570A0 (en) Purging of cells using viruses
CA2213322A1 (en) Thiols to promote hematopoietic progenitor cell growth
SG55145A1 (en) Hematopoietic facilitatory cells and their uses
WO2002024244A3 (en) Method of preparing and processing transplant tissue
PT941329E (pt) Metodo para prevenir a rejeicao de enxertos em transplantacao e para produzir uma celula-hospedeiro para terapia genetica universal utilizando activacao de linfocitos (lag-3)
ATE300310T1 (de) Verfahren zur steigerung von hematopoietischen zellen
WO2002040640A3 (en) Methods of using cd8+/tcr- facilitating cells (fc) for the engraftment of purified hematopoietic stem cells (hsc)
WO1999061589A3 (en) Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof
CA2161798A1 (en) Animal model for hepatitis virus infection
Vigneau et al. Stem cells and kidney injury
MX9304187A (es) Celulas facilitatorias hematopoyeticas.
Stefani et al. Laparoscopic versus surgical transfer of ovine embryos
GB9710698D0 (en) Composition
Mozziconacci et al. Myelodysplastic features developing in Philadephia-negative cells during imatinib mesylate therapy for CML: report of a new case
CA2389896A1 (en) Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation